{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:09:11Z","timestamp":1793664551706,"version":"4.5.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,6,20]],"date-time":"2011-06-20T00:00:00Z","timestamp":1308528000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2011,6,20]],"date-time":"2011-06-20T00:00:00Z","timestamp":1308528000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      In this study, we analysed the number of IL-17\n                      <jats:sup>+<\/jats:sup>\n                      cells in facet joints, in the peripheral blood (PB) and synovial fluid (SF) of spondyloarthritis (SpA) patients and compared these results with those of patients with other rheumatic diseases and controls.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Immunohistochemical analysis of IL-17\n                      <jats:sup>+<\/jats:sup>\n                      cells was performed in facet joints of 33 ankylosing spondylitis (AS) patients and compared with data from 20 osteoarthritis (OA) patients. The frequency of IL-17\n                      <jats:sup>+<\/jats:sup>\n                      CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cells in PB and SF of SpA patients (PB\n                      <jats:italic>n<\/jats:italic>\n                      = 30, SF\n                      <jats:italic>n<\/jats:italic>\n                      = 11), rheumatoid arthritis (RA) patients (PB\n                      <jats:italic>n<\/jats:italic>\n                      = 14, SF\n                      <jats:italic>n<\/jats:italic>\n                      = 7), OA patients (PB\n                      <jats:italic>n<\/jats:italic>\n                      = 10) and healthy controls (PB\n                      <jats:italic>n<\/jats:italic>\n                      = 12) was analysed after stimulation with\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      Enterotoxin B and phorbol 12-myristate 13-acetate\/ionomycin and quantified by flow cytometry.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In AS facet joints, the frequency of IL-17-secreting cells was significantly higher than in samples obtained from OA patients (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001), with a slight predominance of IL-17\n                      <jats:sup>+<\/jats:sup>\n                      cells among the mononuclear cells (61.5% \u00b1 14.9%) compared to cells with polysegmental nuclei. Immunofluorescence microscopy revealed that the majority of IL-17\n                      <jats:sup>+<\/jats:sup>\n                      cells were myeloperoxidase-positive (35.84 \u00b1 13.06\/high-power field (HPF) and CD15\n                      <jats:sup>+<\/jats:sup>\n                      neutrophils (24.25 \u00b1 10.36\/HPF), while CD3\n                      <jats:sup>+<\/jats:sup>\n                      T cells (0.51 \u00b1 0.49\/HPF) and AA-1\n                      <jats:sup>+<\/jats:sup>\n                      mast cells (2.28 \u00b1 1.96\/HPF) were less often IL-17-positive. The frequency of IL-17\n                      <jats:sup>+<\/jats:sup>\n                      CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cells in the PB and SF of SpA patients did not differ significantly compared to RA patients, OA patients or healthy controls.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our data suggest an important role for IL-17 in the inflammatory processes in AS. However, the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/ar3370","type":"journal-article","created":{"date-parts":[[2011,6,21]],"date-time":"2011-06-21T02:25:40Z","timestamp":1308623140000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":301,"title":["Analysis of IL-17+cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response"],"prefix":"10.1186","volume":"13","author":[{"given":"Heiner","family":"Appel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peihua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Scheer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Hempfing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Kayser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Radbruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Loddenkemper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Sieper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,6,20]]},"reference":[{"key":"3108_CR1","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","volume":"369","author":"J Braun","year":"2007","unstructured":"Braun J, Sieper J: Ankylosing spondylitis. Lancet. 2007, 369: 1379-1390. 10.1016\/S0140-6736(07)60635-7.","journal-title":"Lancet"},{"key":"3108_CR2","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.4049\/jimmunol.167.5.2619","volume":"167","author":"LH Boyle","year":"2001","unstructured":"Boyle LH, Goodall JC, Opat SS, Gaston JS: The recognition of HLA-B27 by human CD4+ T lymphocytes. J Immunol. 2001, 167: 2619-2624.","journal-title":"J Immunol"},{"key":"3108_CR3","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/art.20948","volume":"52","author":"P Atagunduz","year":"2005","unstructured":"Atagunduz P, Appel H, Kuon W, Wu P, Thiel A, Kloetzel PM, Sieper J: HLA-B27-restricted CD8+ T cell response to cartilage-derived self peptides in ankylosing spondylitis. Arthritis Rheum. 2005, 52: 892-901. 10.1002\/art.20948.","journal-title":"Arthritis Rheum"},{"key":"3108_CR4","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/1529-0131(200101)44:1<186::AID-ANR25>3.0.CO;2-B","volume":"44","author":"D Baeten","year":"2001","unstructured":"Baeten D, Kruithof E, Van den Bosch F, Demetter P, Van Damme N, Cuvelier C, De Vos M, Mielants H, Veys EM, De Keyser F: Immunomodulatory effects of anti-tumor necrosis factor \u03b1 therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study. Arthritis Rheum. 2001, 44: 186-195. 10.1002\/1529-0131(200101)44:1<186::AID-ANR25>3.0.CO;2-B.","journal-title":"Arthritis Rheum"},{"key":"3108_CR5","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1002\/art.22060","volume":"54","author":"H Appel","year":"2006","unstructured":"Appel H, Kuhne M, Spiekermann S, Ebhardt H, Groszdanovic Z, K\u00f6hler D, Dreimann M, Hempfing A, Rudwaleit M, Stein H, Metz-Stavenhagen P, Sieper J, Loddenkemper C: Immunohistological analysis of zygapophyseal joints in patients with ankylosing spondylitis. Arthritis Rheum. 2006, 54: 2845-2851. 10.1002\/art.22060.","journal-title":"Arthritis Rheum"},{"key":"3108_CR6","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/ni1254","volume":"6","author":"LE Harrington","year":"2005","unstructured":"Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT: Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005, 6: 1123-1132. 10.1038\/ni1254.","journal-title":"Nat Immunol"},{"key":"3108_CR7","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/ni1261","volume":"6","author":"H Park","year":"2005","unstructured":"Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C: A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005, 6: 1133-1141. 10.1038\/ni1261.","journal-title":"Nat Immunol"},{"key":"3108_CR8","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E","volume":"42","author":"M Chabaud","year":"1999","unstructured":"Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, Miossec P: Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum. 1999, 42: 963-970. 10.1002\/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E.","journal-title":"Arthritis Rheum"},{"key":"3108_CR9","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/nm1651","volume":"13","author":"H Kebir","year":"2007","unstructured":"Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M, Giuliani F, Arbour N, Becher B, Prat A: Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med. 2007, 13: 1173-1175. 10.1038\/nm1651.","journal-title":"Nat Med"},{"key":"3108_CR10","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1002\/art.23655","volume":"58","author":"C Jandus","year":"2008","unstructured":"Jandus C, Bioley G, Rivals JP, Dudler J, Speiser D, Romero P: Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides. Arthritis Rheum. 2008, 58: 2307-2317. 10.1002\/art.23655.","journal-title":"Arthritis Rheum"},{"key":"3108_CR11","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1002\/art.24568","volume":"60","author":"H Shen","year":"2009","unstructured":"Shen H, Goodall JC, Hill Gaston JS: Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum. 2009, 60: 1647-1656. 10.1002\/art.24568.","journal-title":"Arthritis Rheum"},{"key":"3108_CR12","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1002\/art.24406","volume":"60","author":"B Vandooren","year":"2009","unstructured":"Vandooren B, Noordenbos T, Ambarus C, Krausz S, Cantaert T, Yeremenko N, Boumans M, Lutter R, Tak PP, Baeten D: Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis. Arthritis Rheum. 2009, 60: 966-975. 10.1002\/art.24406.","journal-title":"Arthritis Rheum"},{"key":"3108_CR13","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jbspin.2006.11.005","volume":"74","author":"D Wendling","year":"2007","unstructured":"Wendling D, Cedoz JP, Racadot E, Dumoulin G: Serum IL-17, BMP-7, and bone turnover markers in patients with ankylosing spondylitis. Joint Bone Spine. 2007, 74: 304-305. 10.1016\/j.jbspin.2006.11.005.","journal-title":"Joint Bone Spine"},{"key":"3108_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/ard.2010.133645","volume":"70","author":"M Rudwaleit","year":"2011","unstructured":"Rudwaleit M, van der Heijde D, Landew\u00e9 R, Akkoc N, Brandt J, Chou CT, Dougados M, Huang F, Gu J, Kirazli Y, Van den Bosch F, Olivieri I, Roussou E, Scarpato S, S\u00f8rensen IJ, Valle-O\u00f1ate R, Weber U, Wei J, Sieper J: The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis. 2011, 70: 25-31. 10.1136\/ard.2010.133645.","journal-title":"Ann Rheum Dis"},{"key":"3108_CR15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S van der Linden","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A: Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum. 1984, 27: 361-368. 10.1002\/art.1780270401.","journal-title":"Arthritis Rheum"},{"key":"3108_CR16","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1002\/art.1780341003","volume":"34","author":"M Dougados","year":"1991","unstructured":"Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, Cats A, Dijkmans B, Olivieri I, Pasero G, Veys E, Zeidler H, the European Spondylarthropathy Study Group: The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 1991, 34: 1218-1227. 10.1002\/art.1780341003.","journal-title":"Arthritis Rheum"},{"key":"3108_CR17","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JG, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-324. 10.1002\/art.1780310302.","journal-title":"Arthritis Rheum"},{"key":"3108_CR18","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1148\/119.3.559","volume":"119","author":"D Resnick","year":"1976","unstructured":"Resnick D, Niwayama G: Radiographic and pathologic features of spinal involvement in diffuse idiopathic skeletal hyperostosis (DISH). Radiology. 1976, 119: 559-568.","journal-title":"Radiology"},{"key":"3108_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/ar7","volume":"1","author":"A Thiel","year":"1999","unstructured":"Thiel A, Radbruch A: Antigen-specific cytometry. Arthritis Res. 1999, 1: 25-29. 10.1186\/ar7.","journal-title":"Arthritis Res"},{"key":"3108_CR20","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.4049\/jimmunol.0903566","volume":"184","author":"AJ Hueber","year":"2010","unstructured":"Hueber AJ, Asquith DL, Miller AM, Reilly J, Kerr S, Leipe J, Melendez AJ, McInnes IB: Mast cells express IL-17A in rheumatoid arthritis synovium. J Immunol. 2010, 184: 3336-3340. 10.4049\/jimmunol.0903566.","journal-title":"J Immunol"},{"issue":"Suppl 1","key":"3108_CR21","doi-asserted-by":"publisher","first-page":">P42","DOI":"10.1186\/1479-5876-8-S1-P43","volume":"8","author":"N Yeremenko","year":"2010","unstructured":"Yeremenko N, Gofita I, Noordenbos T, Tak PP, Canete J, Baeten D: IL-17A producing cells as a therapeutic target in spondyloarthritis. J Transl Med. 2010, 8 (Suppl 1): >P42-","journal-title":"J Transl Med"},{"key":"3108_CR22","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1038\/ng.2007.17","volume":"39","author":"PR Burton","year":"2007","unstructured":"Wellcome Trust Case Control Consortium, Australo-Anglo-American Spondylitis Consortium (TASC), Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, Kwiatkowski DP, McCarthy MI, Ouwehand WH, Samani NJ, Todd JA, Donnelly P, Barrett JC, Davison D, Easton D, Evans DM, Leung HT, Marchini JL, Morris AP, Spencer CC, Tobin MD, Attwood AP, Boorman JP, Cant B, Everson U, Hussey JM, Jolley JD, Knight AS, Koch K, Meech E, et al: Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet. 2007, 39: 1329-1337. 10.1038\/ng.2007.17.","journal-title":"Nat Genet"},{"key":"3108_CR23","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1002\/art.24763","volume":"60","author":"ML DeLay","year":"2009","unstructured":"DeLay ML, Turner MJ, Klenk EI, Smith JA, Sowders DP, Colbert RA: HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis Rheum. 2009, 60: 2633-2643. 10.1002\/art.24763.","journal-title":"Arthritis Rheum"},{"key":"3108_CR24","doi-asserted-by":"publisher","first-page":"e14108","DOI":"10.1371\/journal.pone.0014108","volume":"5","author":"PC Res","year":"2010","unstructured":"Res PC, Piskin G, de Boer OJ, van der Loos CM, Teeling P, Bos JD, Teunissen MB: Overrepresentation of IL-17A and IL-22 producing CD8 T cells in lesional skin suggests their involvement in the pathogenesis of psoriasis. PLoS One. 2010, 5: e14108-10.1371\/journal.pone.0014108.","journal-title":"PLoS One"},{"key":"3108_CR25","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1136\/gut.2007.135053","volume":"57","author":"T Kobayashi","year":"2008","unstructured":"Kobayashi T, Okamoto S, Hisamatsu T, Kamada N, Chinen H, Saito R, Kitazume MT, Nakazawa A, Sugita A, Koganei K, Isobe K, Hibi T: IL23 differentially regulates the Th1\/Th17 balance in ulcerative colitis and Crohn's disease. Gut. 2008, 57: 1682-1689. 10.1136\/gut.2007.135053.","journal-title":"Gut"},{"key":"3108_CR26","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","volume":"27","author":"T Korn","year":"2009","unstructured":"Korn T, Bettelli E, Oukka M, Kuchroo VK: IL-17 and Th17 cells. Annu Rev Immunol. 2009, 27: 485-517. 10.1146\/annurev.immunol.021908.132710.","journal-title":"Annu Rev Immunol"},{"key":"3108_CR27","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1634\/stemcells.2005-0156","volume":"24","author":"W Huang","year":"2006","unstructured":"Huang W, La Russa V, Alzoubi A, Schwarzenberger P: Interleukin-17A: a T-cell-derived growth factor for murine and human mesenchymal stem cells. Stem Cells. 2006, 24: 1512-1518. 10.1634\/stemcells.2005-0156.","journal-title":"Stem Cells"},{"key":"3108_CR28","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.4049\/jimmunol.170.4.2106","volume":"170","author":"S Ferretti","year":"2003","unstructured":"Ferretti S, Bonneau O, Dubois GR, Jones CE, Trifilieff A: IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J Immunol. 2003, 170: 2106-2112.","journal-title":"J Immunol"},{"key":"3108_CR29","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1146\/annurev.immunol.25.022106.141557","volume":"25","author":"CT Weaver","year":"2007","unstructured":"Weaver CT, Hatton RD, Mangan PR, Harrington LE: IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol. 2007, 25: 821-852. 10.1146\/annurev.immunol.25.022106.141557.","journal-title":"Annu Rev Immunol"},{"key":"3108_CR30","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1172\/JCI38702","volume":"120","author":"L Li","year":"2010","unstructured":"Li L, Huang L, Vergis AL, Ye H, Bajwa A, Narayan V, Strieter RM, Rosin DL, Okusa MD: IL-17 produced by neutrophils regulates IFN-\u03b3-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J Clin Invest. 2010, 120: 331-342. 10.1172\/JCI38702.","journal-title":"J Clin Invest"},{"key":"3108_CR31","first-page":"279","volume":"34","author":"HL Malech","year":"1997","unstructured":"Malech HL, Nauseef WM: Primary inherited defects in neutrophil function: etiology and treatment. Semin Hematol. 1997, 34: 279-290.","journal-title":"Semin Hematol"},{"key":"3108_CR32","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/eji.200839088","volume":"39","author":"P Miossec","year":"2009","unstructured":"Miossec P: Diseases that may benefit from manipulating the Th17 pathway. Eur J Immunol. 2009, 39: 667-669. 10.1002\/eji.200839088.","journal-title":"Eur J Immunol"},{"key":"3108_CR33","doi-asserted-by":"publisher","first-page":"52ra72","DOI":"10.1126\/scitranslmed.3001107","volume":"2","author":"W Hueber","year":"2010","unstructured":"Hueber W, Patel DD, Dryja T, Wright AM, Koroleva I, Bruin G, Antoni C, Draelos Z, Gold MH, Psoriasis Study Group, Durez P, Tak PP, Gomez-Reino JJ, Rheumatoid Arthritis Study Group, Foster CS, Kim RY, Samson CM, Falk NS, Chu DS, Callanan D, Nguyen QD, Uveitis Study Group, Rose K, Haider A, Di Padova F: Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci Transl Med. 2010, 2: 52ra72-10.1126\/scitranslmed.3001107.","journal-title":"Sci Transl Med"},{"key":"3108_CR34","first-page":"2840","volume":"62","author":"D Baeten","year":"2010","unstructured":"Baeten D, Sieper J, Emery P, Braun J, van der Heijde D, McInnes I, van Laar JM, Landew\u00e9 R, Wordsworth P, Wollenhaupt J, Kellner H, Paramarta J, Bertolino AP, Wright AM, Hueber W: The anti-IL7A monoclonal antibody secukinumab (AIN457) showed good safety and efficacy in the treatment of active ankylosing spondylitis. Arthritis Rheum. 2010, 62: 2840-2841.","journal-title":"Arthritis Rheum"},{"key":"3108_CR35","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1136\/ard.62.6.561","volume":"62","author":"J Zou","year":"2003","unstructured":"Zou J, Rudwaleit M, Brandt J, Thiel A, Braun J, Sieper J: Up regulation of the production of tumour necrosis factor \u03b1 and interferon \u03b3 by T cells in ankylosing spondylitis during treatment with etanercept. Ann Rheum Dis. 2003, 62: 561-564. 10.1136\/ard.62.6.561.","journal-title":"Ann Rheum Dis"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3370.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar3370\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3370.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T07:04:29Z","timestamp":1728371069000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar3370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,20]]},"references-count":35,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2011,6]]}},"alternative-id":["3108"],"URL":"https:\/\/doi.org\/10.1186\/ar3370","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,20]]},"assertion":[{"value":"14 October 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R95"}}